Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07649512 · ClinicalTrials.gov registry record · NA
Progressive Muscle Relaxation Delivered Via Virtual Reality - an Intervention for Patients Undergoing Cellular Therapy
A NA study, sponsored by University of Arizona.
- Not yet
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT07649512 is a NA study that has not yet begun recruiting, run by University of Arizona. The registered enrollment target is 40 participants.
The verdict
NCT07649512, a NA study, has not yet begun recruiting, sponsored by University of Arizona.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
Patients planned for cellular therapy supplementation such as CAR-T or stem cell transplant who are admitted for atleast 7 days in patient. During that time of admission, patients enrolled will complete a once daily, virtual reality guided progressive muscle relaxation program. Various validated QOL tools will be utilized to assess study results.
Interventions
- COMBINATION_PRODUCT Progressive Muscle Relaxation delivered via Virtual Reality
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2026-08 |
| Est. Completion | 2027-05-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07649512
The ClinicalTrials.gov registry entry for NCT07649512 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Progressive Muscle Relaxation delivered via Virtual Reality is the first listed.
NCT07649512 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07649512 about?
NCT07649512 is a clinical study titled "Progressive Muscle Relaxation Delivered Via Virtual Reality - an Intervention for Patients Undergoing Cellular Therapy". Patients planned for cellular therapy supplementation such as CAR-T or stem cell transplant who are admitted for atleast 7 days in patient. During that time of admission, patients enrolled will complete a once daily, virtual reality guided progressive muscle relaxation program. Various validated QOL...
What is the current status of trial NCT07649512?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2026-08. Estimated completion is 2027-05-01.
What interventions are being tested in trial NCT07649512?
The interventions under investigation include: Progressive Muscle Relaxation delivered via Virtual Reality (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT07649512?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.